Patent directory · USPTO A61K / A61P
Patents matching “MIRAGEN THERAPEUTICS, INC.”
18 pharma patents match "MIRAGEN THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 18 pharmaceutical patents matching "MIRAGEN THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10337005
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 10316318
Oligonucleotide compositions and uses thereof
granted -
US 10280422
MiR-92 inhibitors and uses thereof
granted -
US 10144930
Inhibitors of MYH7B and uses thereof
granted -
US 10011833
Bridged bicyclic nucleosides
granted -
US 9994852
Oligonucleotide compositions and uses thereof
granted -
US 9994847
miR-29 mimics and uses thereof
granted -
US 9885042
miR-92 inhibitors and uses thereof
granted -
US 9803202
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 9771585
miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
granted -
US 9752144
Inhibitors of MYH7B and uses thereof
granted -
US 9752143
Locked nucleic acid inhibitor of miR-145 and uses thereof
granted -
US 9416360
Base modified oligonucleotides
granted -
US 9388408
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 9376681
miR-29 mimics and uses thereof
granted -
US 9163235
Inhibitors of the miR-15 family of micro-RNAs
granted -
US 9012225
Lipophilic polynucleotide conjugates
granted -
US 8642751
MicroRNA inhibitors comprising locked nucleotides
granted